Seroprevalence (95% confidence interval) | |||||
---|---|---|---|---|---|
N | n | Crude % [95%CI] | Age-sex-location-weighteda % [95%CI] | Age-sex-location-weighted. Adjusted by test characteristicb % [95%CI] | |
Overall | 7593 | 4884 | 64.3 [63.2–65.4] | 61.8 [60.7–62.9] | 65.5 [64.3–66.6] |
Age group (years) | |||||
< 10 | 937 | 445 | 47.5 [44.3–50.7] | 47.2 [44–50.4] | 50 [46.6–53.4] |
10–14 | 738 | 424 | 57.5 [53.9–61] | 56 [52.8–59.2] | 59.3 [55.9–62.7] |
15–19 | 483 | 321 | 66.5 [62.2–70.7] | 66.1 [62.6–69.5] | 70 [66.3–73.7] |
20–29 | 1266 | 830 | 65.6 [62.9–68.2] | 63.4 [60.6–66.2] | 67.2 [64.2–70.2] |
30–39 | 1640 | 1145 | 69.8 [67.6–72] | 69.8 [66.8–72.9] | 74 [70.8–77.3] |
40–49 | 1153 | 789 | 68.4 [65.7–71.1] | 67.7 [63.9–71.5] | 71.8 [67.7–75.8] |
50–59 | 767 | 518 | 67.5 [64.2–70.8] | 65.7 [60.5–70.9] | 69.7 [64.2–75.2] |
60–70 | 382 | 270 | 70.7 [66.1–75.2] | 66.9 [64–69.8] | 70.9 [67.8–74] |
70+ | 227 | 142 | 62.6 [56.3–68.9] | 60.1 [57.5–62.7] | 63.7 [61–66.4] |
Sex | |||||
Female | 4164 | 2689 | 64.6 [63.1–66] | 61.1 [59.5–62.6] | 64.7 [63.1–66.3] |
Male | 3429 | 2195 | 64 [62.4–65.6] | 62.5 [61–64] | 66.2 [64.6–67.8] |
Location | |||||
Rural | 3593 | 2184 | 60.8 [59.2–62.4] | 58.5 [57.2–59.9] | 62.0 [60.6–63.5] |
Urban | 4000 | 2700 | 67.5 [66.0–69.0] | 67.3 [65.6–69] | 71.3 [69.5–73.1] |
Already vaccinated against COVID-19 (n = 6240) | |||||
No | 4924 | 3102 | 63.0 [61.6–64.3] | 61.6 [59.1–63.0] | 65.1 [63.7–67.4] |
Yes | 1316 | 1102 | 83.7 [81.7–85.7] | 81.7 [79.5–83.8] | 86.5 [84.2–88.8] |